Venomyx Therapeutics

Venomyx Update May 21st, 2019

follower @ Venomyx Therapeutics

Published on May 22, 2019

Hello to our Venomyx investors! The team and myself would like to thank you all for your incredible support and provide some quick updates.... It's a very exciting time in the lab! We have been preparing to initiate multiple key projects made possible by your investments including small-scale manufacturing of our candidates, screening to expand our candidates' species efficacy, and preclinical testing. We also have a new potential corporate partner that would be instrumental in providing guidance and resources for our clinical trials!

To show our appreciation, we have decided to add additional perks to our investors as well as lower the threshold amount to obtain these for those who have already invested! Please keep an eye on our page for these updates and we will be contacting you following the close to obtain information on where to send your items!


This is a pivotal moment for Venomyx and we are in a very good position to bring our modern recombinant antivenom to market to save lives and limbs. Thanks to each of you for your support and for choosing to make a difference!


Sincerely,
Dan T. Dempsey, CEO"